Tumor volume as a prognostic factor on the median survival in locally advanced oral cancer treated with definitive chemoradiotherapy.

Autor: Janmunee N; Department of Radiology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand., Peerawong T; Department of Radiology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand., Rordlamool P; Department of Radiology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand., Bridthikitti J; Department of Radiology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand., Tangthongkum M; Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand., Kongkamol C; Research Unit of Holistic Health and Safety Management in the Community , Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand., Hirunpat S; Department of Radiology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
Jazyk: angličtina
Zdroj: Indian journal of cancer [Indian J Cancer] 2021 Jan 27. Date of Electronic Publication: 2021 Jan 27.
DOI: 10.4103/ijc.IJC_86_20
Abstrakt: Background: Surgery has been the mainstay treatment for oral cancer. Those patients, who do not receive surgery are generally treated with concurrent chemoradiotherapy (CCRT). Many factors play a role in patients' survival; tumor volume might be one of those factors. This study aims to determine the effect of the pretreatment tumor volume on the survival of oral cancer.
Methods: Retrospective study of patients with histological confirmed squamous cell carcinoma, stage III-IV oral cancer, who received definitive CCRT. Tumor volume from pretreatment computed tomography (CT) scans were reviewed and analyzed. The optimal cut-off tumor volume was evaluated by receiver operating characteristic (ROC) curve analysis.
Results: From 67 patients, half of the primary tumor sites were oral tongue. The median total tumor volume (TTV) was 73.25 cm 3 , while the median survival was 12.5 months (95% CI 10.9-20.3). The optimal cut-off TTV =52.9 cm 3 (P < 0.0001). The median survival of the patients, who had tumor volume <52.9 cm 3 were 34.4 months, and for tumor volume =52.9 cm 3 were 8.6 months (P < 0.0001). Multivariate analysis showed that TTV =52.9 cm 3 , and intensity-modulated radiotherapy (IMRT) or volumetric modulated arc (VMAT) technique had significantly influenced on the overall survival.
Conclusions: TTV had an influence on the overall survival of locally advanced oral cancer. In addition, TTV may be considered as a factor in selecting the appropriate treatment option for these patients.
Competing Interests: None
Databáze: MEDLINE
Externí odkaz: